ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative68.01 M130.41 M94.54 M91.65 M97.27 M413.86 MRicerca e sviluppo——————Reddito operativo391.46 M183.31 M302.79 M347.47 M433.75 M1.27 BProventi non operativi, Totale——————Oneri finanziari, al netto degli interessi capitalizzati——————Proventi non operativi, esclusi gli oneri finanziari——————Entrate/uscite straordinarie——————Utile al lordo delle imposte102.88 M52.58 M76.48 M90.95 M122.91 M342.92 MQuota di utile——————Imposte11.88 M-21.59 M15.04 M16 M23.73 M33.18 MInteressi di minoranza39.69 M20.15 M28.54 M35.12 M45.82 M129.62 MAltri proventi/oneri al netto delle imposte-2.23 M210 K5.02 M1.24 M-2.54 M3.93 MUtile netto al lordo delle attività cessate51.3 M54.02 M32.9 M39.84 M53.36 M180.12 MAttività cessate——————Utile netto51.3 M54.02 M32.9 M39.84 M53.36 M180.12 MRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari82.24 M88.63 M52.38 M65.25 M-15.09 M191.17 MUtile base per azione (EPS base)2.022.121.261.552.077Utile diluito per azione (EPS diluito)1.841.991.221.491.986.68Numero medio di azioni ordinarie in circolazione25.45 M25.52 M25.68 M25.7 M25.72 M102.63 MAzioni diluite in circolazione44.11 M44.46 M43.95 M43.9 M28.61 M160.92 MEBITDA106.08 M55.79 M79.76 M94.36 M126.35 M356.26 MEBIT102.88 M52.58 M76.48 M90.95 M122.91 M342.92 MCosto del fatturato——————Altri costi del venduto——————Ammortamento e svalutazione (liquidità)3.21 M3.21 M3.28 M3.41 M3.44 M13.34 M
PJT Partners Inc Class A
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
PJT operates businesses across strategic advisory, strategic capital markets, restructuring, shareholder advisory and capital raising. The firm has advised on over $1 trillion in M&A transactions including AbbVie's $63 billion acquisition of Allergan, T-Mobile's $59 billion merger with Sprint, and Mylan's $50 billion merger with Pfizer subsidiary, Upjohn.
The firm is headquartered in New York City, with additional offices in Boston, Chicago, Hong Kong, Houston, London, Los Angeles, Madrid, San Francisco and Sydney, and employs approximately 700 people.